UBS Group AG

Position in LUCD — Lucid Diagnostics Inc.

CIK 1610520 ZURICH, V8

Position in LUCD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$904,485

+$392,186 QoQ

Shares Held

845,314

+89.8% QoQ

Ownership

0.416%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 114 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,660,030,787 across 135 Medical Devices names. LUCD ranks #64 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	16,352,420	$697,921,281
2	ABT	Abbott Laboratories	7,356,093	$667,491,874
3	SYK	Stryker Corp	1,909,680	$601,243,647
4	MDT	Medtronic plc	5,551,443	$434,289,383
5	DXCM	Dexcom Inc	6,065,779	$408,530,211
6	ZBH	Zimmer Biomet Holdings, Inc.	2,758,615	$237,489,163
7	PEN	Penumbra Inc	703,822	$222,231,795
8	EW	Edwards Lifesciences Corp	2,350,656	$212,640,338

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$904,485	845,314	+89.8%	Shares	Defined	2026-08-13
2026-03-31	$512,299	445,479	+43.9%	Shares	Defined	2026-05-05
2025-12-31	$337,347	309,494	+113.1%	Shares	Defined	2026-01-29
2025-09-30	$146,696	145,244	+117.5%	Shares	Defined	2025-11-13
2025-06-30	$76,802	66,785	+1041.6%	Shares	Defined	2025-08-14
2025-03-31	$8,716	5,850	+292400.0%	Shares	Defined	2025-05-13
2024-09-30	$1	2	-100.0%	Shares	Sole	2024-11-14
2023-12-31	$8,048	5,708	+3.5%	Shares	Sole	2024-02-09
2023-09-30	$6,453	5,516	+115.6%	Shares	Sole	2023-11-09
2023-03-31	$3,581	2,558	-28.2%	Shares	Sole	2023-05-12
2022-12-31	$4,848	3,565	-28.1%	Shares	Sole	2023-02-08
2022-09-30	$7,590	4,961	+8.2%	Shares	Sole	2022-11-10
2022-06-30	$10,366	4,587	+209.1%	Shares	Sole	2022-08-10
2022-03-31	$4,986	1,484	-21.4%	Shares	Sole	2022-05-16
2021-12-31	$10,138	1,888	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.